NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH METOCLOPRAMIDE

被引:18
作者
PATTERSON, JF [1 ]
机构
[1] UNIV MISSOURI,DEPT PSYCHIAT,COLUMBIA,MO 65201
关键词
D O I
10.1097/00007611-198805000-00035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:674 / 675
页数:2
相关论文
共 7 条
[1]   NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].
BURKE, RE ;
FAHN, S ;
MAYEUX, R ;
WEINBERG, H ;
LOUIS, K ;
WILLNER, JH .
NEUROLOGY, 1981, 31 (08) :1022-1026
[2]  
FRIEDMAN JH, 1984, ANN NEUROL, V16, P126
[3]   NEUROLEPTIC MALIGNANT SYNDROME - SUCCESSFUL TREATMENT WITH DANTROLENE AND BROMOCRIPTINE [J].
GRANATO, JE ;
STERN, BJ ;
RINGEL, A ;
KARIM, AH ;
KRUMHOLZ, A ;
COYLE, J ;
ADLER, S .
ANNALS OF NEUROLOGY, 1983, 14 (01) :89-90
[4]   NEUROLEPTIC MALIGNANT SYNDROME [J].
MUELLER, PS .
PSYCHOSOMATICS, 1985, 26 (08) :654-&
[5]  
SCHULZEDELRIEU K, 1979, GASTROENTEROLOGY, V77, P768
[6]   THE NEUROLEPTIC MALIGNANT SYNDROME - AGENT AND HOST INTERACTION [J].
SHALEV, A ;
MUNITZ, H .
ACTA PSYCHIATRICA SCANDINAVICA, 1986, 73 (04) :337-347
[7]  
SIMPSON DM, 1984, AM J PSYCHIAT, V141, P796